Shares of the gene therapy company were reported 3% up in premarket trading on Monday. At 811 pence per share, Oxford Biomedica is more than 20% up year to date in the stock market after recovering from a low of 400 pence per share in March. At the time of writing, the UK company has a market capitalisation of £624.66 million.